Leading Manufacturer and Exporter of Cisplatin Injection in India

Taj Pharmaceuticals Ltd, a trusted name in the global pharmaceutical industry, is a top manufacturer, exporter, and supplier of Cisplatin Injection from Vapi, Gujarat, India. Known for its commitment to quality, purity, and global healthcare excellence, Taj Pharma has established itself as a pioneer in oncology product manufacturing, delivering life-saving cancer medications at competitive prices across India, Africa, the Middle East, and Latin America (LTAM).

About Cisplatin Injection

Cisplatin Injection is a platinum-based chemotherapy medication widely used in the treatment of ovarian cancer, cervical cancer, testicular cancer, and several other malignancies such as lung, bladder, head, and neck cancers. It works by binding to the DNA of cancer cells, thereby disrupting their replication and leading to cell death.

As a potent anti-neoplastic agent, Cisplatin is administered intravenously under the supervision of a qualified oncologist. Taj Pharmaceuticals manufactures Cisplatin Injection 50mg and 10mg formulations under stringent quality control standards compliant with WHO-GMP, ISO, and global pharmacopeial norms.

Why Choose Taj Pharmaceuticals for Cisplatin Injection Manufacturing

1. State-of-the-Art Manufacturing Facility

At Taj Pharmaceuticals, Cisplatin Injection is produced in ultra-modern facilities in Vapi, Gujarat, equipped with advanced sterile filling lines and cleanroom environments. Every vial undergoes rigorous testing to ensure purity, potency, and stability in accordance with global regulatory standards (USFDA, MHRA, TGA, and WHO-GMP).

2. Global Reach and Export Network

Taj Pharma proudly exports Cisplatin Injection to over 80+ countries, with strong distribution partnerships across Africa, the Middle East, Latin America, and CIS regions. The company ensures on-time delivery, pharma-grade packaging, and compliance with international export documentation, making it one of the most reliable suppliers globally.

3. Commitment to Quality and Compliance

Quality assurance is at the heart of Taj Pharma’s operations. Every batch of Cisplatin Injection undergoes in-process testing, stability studies, and microbiological validation to meet stringent pharmacopeial specifications (IP, BP, USP, and EP).

4. Research-Driven Oncology Expertise

With years of expertise in oncology formulations, Taj Pharmaceuticals invests heavily in R&D and formulation development. Their team of scientists, pharmacists, and quality experts ensures that each product meets the highest therapeutic standards and provides consistent efficacy in cancer care.

Cisplatin Injection – Product Information

Generic Name of the Medicinal Product

Cisplatin Injection

Qualitative and Quantitative Composition

Each vial contains:

• Cisplatin IP/USP: 50 mg or 10 mg
• Excipients: Sodium chloride, hydrochloric acid, and water for injection q.s.

Dosage Form

Sterile Solution for Injection

Therapeutic Indications

Cisplatin Injection is indicated for the treatment of:

• Testicular cancer (metastatic)
• Ovarian carcinoma (advanced stage)
• Cervical carcinoma
• Bladder cancer
• Lung cancer (non-small cell and small cell)
• Head and neck cancers

Mechanism of Action

Cisplatin interferes with the replication of DNA by forming cross-links between DNA strands, thereby preventing cell division and inducing apoptosis (cell death) in rapidly dividing cancer cells.

Route of Administration

Intravenous (IV) infusion under medical supervision.

Dosage

The dosage is individualized based on body surface area, type of cancer, and patient response. Typically:

• Testicular cancer: 20 mg/m² IV daily for 5 days
• Ovarian cancer: 75–100 mg/m² IV every 3–4 weeks
• Cervical cancer: 40 mg/m² weekly (in combination with radiotherapy)

Storage

Store between 2°C to 8°C. Protect from light and freezing. Keep out of reach of children.

Caution and Warning

• Administer only under medical supervision.
• Avoid contact with aluminum during preparation or administration.
• Monitor renal function, electrolytes, and hematologic parameters before each cycle.
• Contraindicated in patients with renal impairment or hearing loss.

Technical Specification of Cisplatin Injection

Cisplatin Injection Manufacturer and Supplier in India

Taj Pharmaceuticals is one of the leading Cisplatin Injection manufacturers and suppliers in India, offering PAN India distribution from Mumbai, Maharashtra, and Vapi, Gujarat. Our Cisplatin Injection 50mg and 10mg are available at competitive bulk and PCD franchise prices.

We serve hospitals, oncology centers, government tenders, and pharmaceutical distributors with high-quality, ready-for-export Cisplatin Injections that meet all regulatory and pharmacopeial standards.

Cisplatin Injection Exporters and Global Suppliers

As a global exporter, Taj Pharma has established its footprint in Africa (Nigeria, Kenya, Ghana, Ethiopia), Middle East (UAE, Saudi Arabia, Oman, Kuwait), and Latin America (Peru, Chile, Brazil). With logistics expertise and export compliance, we guarantee timely dispatch and reliable delivery worldwide.

Partner with Taj Pharma – Your Trusted Oncology Partner

Taj Pharmaceuticals offers PCD Pharma Franchise, Third-Party Manufacturing, and Global Supply Partnerships for Cisplatin Injection and other oncology formulations. We are committed to supporting partners with:

• WHO-GMP certified production
• Attractive monopoly-based franchise rights
• Marketing and promotional support
• Transparent business ethics

Contact Taj Pharmaceuticals for Cisplatin Injection Supply

If you are a pharma distributor, importer, or hospital buyer, connect with Taj Pharmaceuticals Ltd to source Cisplatin Injection 50mg and Cisplatin Injection 10mg at the best market prices.

📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
Tel.: +91-22-2637 4592 / 2637 4593
📠 Fax: +91-22-2634 1274